Twist Bioscience Corporation Current Assets
Twist Bioscience Corporation (TWST) had Current Assets of $321.30 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-03
- 2026-06-30: Assets, Current $321.30M.
- 2026-03-31: Assets, Current $323.44M.
- 2025-12-31: Assets, Current $303.88M.
- 2025-09-30: Assets, Current $332.97M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $321.30M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $323.44M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $303.88M 10-Q/A · filed 2026-02-26 |
| 2025-09-30 | $332.97M 10-Q · filed 2026-08-03 |
| 2025-06-30 | $339.78M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $338.44M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $345.31M 10-Q · filed 2025-02-03 |
| 2024-09-30 | $346.78M 10-K · filed 2025-11-17 |
| 2024-06-30 | $361.83M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $371.87M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $390.23M 10-Q · filed 2024-02-02 |
| 2023-09-30 | $424.26M 10-K · filed 2024-11-18 |
| 2023-06-30 | $445.54M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $489.27M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $541.86M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $596.48M 10-K · filed 2023-11-21 |
| 2022-06-30 | $624.12M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $664.38M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $385.01M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $546.50M 10-K/A · filed 2023-06-05 |
| 2021-06-30 | $576.61M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $608.00M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $634.43M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $334.87M 10-K · filed 2021-11-23 |
| 2020-06-30 | $344.58M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $260.20M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $129.29M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $160.13M 10-K · filed 2020-11-27 |
| 2019-06-30 | $182.62M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $120.99M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $146.66M 10-Q · filed 2019-02-11 |
| 2018-09-30 | $95.67M 10-K · filed 2019-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |